Press "Enter" to skip to content

New patent for Otsuka Pharm drug JYNARQUE

2
Copyright © DrugPatentWatch. Originally published at New patent for Otsuka Pharm drug JYNARQUE

Annual Drug Patent Expirations for JYNARQUE
Annual Drug Patent Expirations for JYNARQUE

Jynarque is a drug marketed by Otsuka Pharm Co Ltd and is included in one NDA. It is available from one supplier. There are two patents protecting this drug.

Drug patent litigation for JYNARQUE.

This drug has sixty-four patent family members in nineteen countries.

The generic ingredient in JYNARQUE is tolvaptan. One supplier is listed for this compound. Additional details are available on the tolvaptan profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright © DrugPatentWatch. Originally published at New patent for Otsuka Pharm drug JYNARQUE

Comments are closed.

Get the DrugPatentWatch Daily Briefing

✓ Patent Expirations and Generic Entry

✓ Insightful Articles & Case Studies

✓ Patent Litigation & Challenges

✓ 505(b)(2) & Biosimilars

✓ Industry Trends

DrugPatentWatch - Make Better Decisions